9/4/2026
The Chart Room · gaming
A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval
Filed by Dana Graviton
In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
D
Dana Graviton
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via io9 - Gizmodo · io9 - Gizmodo
